WO2021089972A1

WO2021089972A1 - Feed or feed supplement for livestock animals

Info

Publication number: WO2021089972A1
Application number: PCT/FR2020/052043
Authority: WO
Inventors: Abdeslam El Harrak; César Adrien Claude René CRETEL
Original assignee: Huddle Corp
Priority date: 2019-11-07
Filing date: 2020-11-09
Publication date: 2021-05-14
Also published as: FR3102912B1; FR3102912A1

Abstract

The invention relates to a feed or a feed supplement in the form of modularly stacked objects for the controlled release of nutrients and/or physiologically active substances for monogastric animals, comprising a core having an aqueous phase dispersed in a lipid matrix, and a coating of the core, wherein the object comprises a gelled protein phase disposed between said lipid matrix and said coating.

Description

Food or food supplement for farm animals Field of the invention

[0001] The subject of the invention is a food or a food supplement for monogastric farm animals, in particular fish. In particular, the invention relates to foods or food supplements allowing controlled release of the active substances which they contain.

State of the art

[0002] It is well known to use physiologically active substances to supplement the food of farm animals to improve their health conditions and accelerate their growth.

[0003] Such physiologically active substances can be proteins, lipids, carbohydrates, but also vitamins and any form of food supplementation aimed at prebiotics, probiotics, amino acids, antioxidants, or other molecules (ie essential oils) aimed at nutraceutical or therapeutic direct or indirect.

[0004] The diversity of the conditions in which food is ingested and digested requires a response adapted to each species and to each stage of maturity of the animals.

[0005] By way of example, the document JPH10327770 describes microcapsules containing an aqueous phase with water-soluble active substances dispersed in a lipid phase with fat-soluble active substances, the whole being coated with a biodegradable polymer dispersed during preparation in an oil / organic solvent mixture. The microcapsules have a size of 5 to 20 μm and are suitable for feeding rotifers, which are themselves prey for farmed fry. As examples of biodegradable coating polymers, there are cited polysaccharides, polypeptides, aliphatic polyesters and gelatin. Polysaccharides are preferred. The process for preparing the coating system described in this document requires placing the coating biopolymer in solution in an organic solvent, which is not recommended for a product intended to enter the food chain. In addition, the coating system can only be dissolved in the animal's digestive system by splitting the chains. This requires appropriate kinetics and enzymes often obtained by the action of the microbiota at the end of the tube. digestive. For example, cellulose is not digestible in fish because they cannot operate these chain splits. As a result, digestion can be slowed down and delayed by the poor digestibility of the fibers used.

[0006] Interest remains in foods or food supplements whose structures and manufacturing processes make it possible to offer a response adapted to each species and to each stage of maturity of the animals.

[0007] And in particular, there is a need for foods and food supplements which allow rapid release of active substances or nutrients but sequenced, that is to say in specific and identified areas of the digestive system of the target animal for better metabolism of these nutrients.

Brief description of the invention

[0008] The subject of the invention is the following products:

Food or food supplement, in the form of objects O with modular stacks allowing a controlled release of nutritive and / or physiologically active substances for monogastric animals, comprising a core 12 comprising an aqueous phase A dispersed in a lipid matrix 18, and a coating 14 of the core 12, characterized in that the said product comprises a gelled protein phase 11 arranged between the said lipid matrix 18 and the said coating 14.

1. Food or food supplement allowing a controlled release of nutritive and / or physiologically active substances for monogastric animals, comprising a core 12 comprising an aqueous phase A containing water-soluble active substances dispersed in a lipid matrix 18 containing liposoluble active substances, and a coating 14 of the core 12, such that the product comprises a gelled protein phase 11 arranged between the lipid matrix 18 and the coating 14 and such that the protein level of the protein phase 11 is between 6 and 95% by weight per relative to the weight of a dry extract of the protein phase 11. The food or food supplement is thus in the form of modular stacking objects O.

2. Food or food supplement according to product 1, in which the protein level of the protein phase 11 is between 45 and 80% by weight relative to the weight of a dry extract of the protein phase 11. 3. Food or food supplement according to one of the products 1 and 2, in which the total protein content of the product is between 3 and 80% by weight relative to the weight of a dry extract of the product.

4. Food or food supplement according to any one of the preceding products, in which the protein phase comprises neutral or functionalized negatively charged polysaccharides, gellable and functionalized with a function chosen from the group of carboxylic, sulphonate, alcoholate or phosphate functions, preferably. carboxylic.

5. Food or food supplement according to product 4, in which the negatively charged polysaccharides are chosen from the group of alginate, pectin, xanthan, gellan gum and their mixtures.

6. Food or food supplement according to product 4 or 5, and in which the gelled protein phase 11 is crosslinked by the action of a gelling agent released with a delay time which may be a metal which can complex with the functions of the polysaccharides. or an inorganic or organic oligomer of opposite charge to the charge of the target polysaccharide, and in which the gelling agent comprises cations of calcium, zinc, magnesium, iron or transition metals and a source of acidic protons hydrolyzable in water, allowing the release of the ionic form under the action of protons. 7. Food or food supplement according to any one of the preceding products, in which the gelled protein phase 11 comprises a content of gellable polysaccharides of between 2 and 20% by weight and preferably between 2% and 10% relative to the weight of 'a dry extract of the protein phase 11.

8. Food or food supplement according to any of the preceding products, in which the proteins of the gelled protein phase 11 contain proteins of size less than 30 kDa.

Food or food supplement according to any one of the preceding products, in which the content of the protein phase in all of the objects is between 5 and 75% by weight relative to the weight of all of the objects. 9. Food or food supplement according to any one of the preceding products, in which the protein phase 11 comprises a mineral load, for example clay.

10. Food or food supplement according to any of the preceding products, in which the protein phase 11 comprises an osmotic agent. 11. Food or food supplement according to product 10, in which the osmotic agent is chosen from the group of sugars, salts, water-soluble polymers, preferably with a molecular mass of less than 150 kg / mole, and mixtures thereof.

12. Food or food supplement according to any of the preceding products, in which the protein phase 11 is of any shape with a greater dimension of between 500 μm and 5 mm.

Food supplement according to any of the preceding products, in which the protein content of the protein phase is between 10 and 20% by weight relative to the weight of the whole object after final drying.

Food according to any one of products 1 to 12, in which the content of the protein phase is between 20 and 70% by weight based on the weight of the whole object after final drying.

13. Food supplement according to any of the preceding products, in which the total protein content of the product is between 3 and 40% by weight relative to the weight of a dry extract of the whole product. 14. Food according to any one of products 1 to 12, in which the total protein content of the product is between 40 and 80% by weight relative to the weight of a dry extract of the whole product.

[0009] The presence of this protein phase has the advantage of providing the target animal, in addition to the active substances, with the amino acids necessary for its growth, and of promoting the baitiness of the food.

Description of Figures

The invention is described below with the aid of Figures 1 to 13, given solely by way of illustration: - [Fig. 1] shows schematically in section and without respecting the respective dimensions a first product object of the invention;

- [Fig. 2] shows schematically in section a second product of the invention;

- [Fig. 3] shows schematically an embodiment of the coating of a product of the invention;

- [Fig. 4] shows a diagram of a manufacturing process for the first product; and

- [Fig. 5] shows a diagram of the additional steps for the manufacture of the second product;

- [Fig. 6] shows the size distribution of aqueous particles;

- [Fig. 7] shows the size distribution of lipid particles;

- [Fig. 8] shows the change in the iodine number measured during aging in the air free of lipid particles;

- [Fig. 9] shows an image of a lipid particle obtained under a scanning electron microscope;

- [Fig. 10] presents a curve for monitoring the rheological behavior of a protein layer;

- [Fig. 11] shows an example of protein particles obtained after gelation;

- [Fig. 12] presents the conductimetric monitoring of metered additions of biopolymers loaded in water; and

- [Fig. 13] shows the evolution of the conductivity of lipid particles as a function of metered additions of charged biopolymers.

Detailed description of the invention

The various constituent parts of foods or food supplements according to the invention will be called "object" or "element".

The food and food supplements according to the invention, obtained by stacking the various objects, will be called "product".

By "gel" is meant a material mainly consisting of liquid, but which has a behavior close to that of a solid thanks to a three-dimensional network entangled within the liquid. It is these tangles that give gels their structure and their properties. The three-dimensional network of solids diluted in the liquid can be the result of chemical or physical bonds, or small crystals or other bonds that remain intact in the dispersing liquid.

In the context of the present invention, by the term "exfoliated mineral filler" is meant a mineral filler which has undergone exfoliation, that is to say a more or less complete separation of its individual layers. The exfoliation process usually comprises three phases:

- (1) Pre-swelling of the phyllosilicate sheets by swelling in water,

- (2) The adsorption of a hydrophobic molecule at the surface of the particles of phyllosilicates, to make it compatible with the lipid phase of dispersion, for example lecithin, and

- (3) The supply of shear energy to separate the particles of phyllosilicates in solution.

In the context of the present invention, the specific surface (Ss) also called "mass area" represents the surface of the object (As) per unit of mass (M) and is generally expressed in m ² / g. Specific area refers to the actual area of the accessible area of an object as opposed to its apparent area.

[0016] Figure 1 shows schematically and in section without respecting the respective dimensions of each phase a first product comprising a protein phase 11 according to one of the objects of the invention.

This first product 10 comprises a core 12, a protein phase 11 and a coating 14 of the whole of the core 12 and of the protein phase 11. The core 12 comprises an aqueous phase A in the form of spherical gelled particles (or irregular) 16, the particles 16 are dispersed in a lipid matrix 18. The protein phase 11 surrounds the core 12 and is surrounded by the coating 14.

A first element or object of this first product 10 is that it contains a gelled aqueous phase A containing water-soluble active substances, including in particular nutrients. Thus, the gelled particles 16 contain water-soluble active substances, including in particular nutrients. Advantageously, the size of the gelled particles 16 is between 1 and 200 μm and preferably between 20 and 100 μm.

The gelation of the aqueous phase A makes it possible to limit the leakage of nutrients and of the active substances outside the particles 16. It also allows a stabilization of the size of the particles 16 by limiting the coalescence and therefore increasing the specific surface of the aqueous phase A, namely the sum of the specific surfaces of each gelled particle 16, and therefore to accelerate the rate of release of the active substances which it contains in the digestion phase.

According to a preferred embodiment, the aqueous phase A comprises an anionic polysaccharide such as an alginate with a content of between 1 and 4% by weight relative to the weight of the aqueous phase.

According to a preferred embodiment, the aqueous phase A comprises a carboxylic functionalized polysaccharide, and thus negatively charged under the appropriate pH conditions, such as an alginate with a content of between 1 and 8% by weight of carboxylic functionalized polysaccharide by relative to the weight of a dry extract of the aqueous phase A, that is to say relative to the weight of a dry extract of all the gelled particles 16, and advantageously between 1 and 5.5% in weight, more preferably between 1 and 4% by weight.

[0023] The aqueous phase A can advantageously be gelled by reacting the anionic polysaccharide, advantageously carboxylic functionalized, with reagents such as a calcium salt as well as pyrophosphate or deltagluconolactone.

The calcium salt can be chosen from the group of calcium sulphate, carbonate, lactate, citrate, tartrate, caseinate and stearate, and mixtures thereof, in particular from the group of calcium sulphate, carbonate and stearate, and their mixtures. The solubility of the calcium salt is obtained by reaction with protons (acids) released in situ. They can be generated by reactants such as pyrophosphates or deltagalactolactone in contact with water.

Advantageously, the aqueous phase A further comprises an osmotic agent. This osmotic agent can be chosen from the group of sugars, salts, water-soluble polymers, preferably with a molecular mass of less than 150 kg / mole, and their combinations.

A preferred choice of osmotic agent can be sorbitol with a content of less than 5% by weight relative to the weight of the aqueous solution, that is to say of the aqueous phase A (in its complete formulation) , so as not to make the final product indigestible. A content of between 0.8 and 1.5% by weight of sorbitol is optimal. Guérande salt can also be used advantageously, which also makes it possible to provide useful mineral salts.

Preferably, the content of the aqueous phase A dispersed in the lipid matrix 18, and thus the content of gelled particles 16, is between 10 and 50% by volume, and preferably between 15 and 30% by volume relative to the total volume of the aqueous phase A and of the lipid matrix 18, that is to say relative to the total volume of the core 12.

Below 10% by volume, the volume of the aqueous phase A is no longer sufficient to easily introduce the water-soluble active substances and have good homogeneity of composition of the cores 12 of the products.

Beyond 50% by volume, it becomes much more difficult to keep a dispersed water emulsion, that is to say the gelled particles 16, in the lipid phase 18. [0032] The gelled aqueous phase A , and thus the gelled particles 16, can include hydrophilic active substances such as amino acids, vitamins, prebiotics, probiotics, antioxidants, and combinations thereof.

A second element of this first product 10 is that the aqueous phase 16, that is to say the gelled particles 16, is dispersed in a matrix or lipid phase 18. Advantageously, the lipid matrix 18 comprises at least a vegetable or animal oil, in particular from fish, and at least one crystallizable wax. Waxes can be of animal (beeswax) or vegetable origin.

Preferably, the waxes used are crystallizable waxes with a melting point of less than 90 degrees Celsius and very preferably less than 65 degrees Celsius. The wax content is advantageously between 5 and 25% by weight relative to the weight of the whole of the lipid matrix 18, and very advantageously between 10 and 20%.

According to preferred embodiments, the lipid matrix 18 is of substantially spherical shape and thus the core is of substantially spherical shape and of diameter between 10 and 1000 mhi and preferably between 200 and 400 mhi.

The lipid matrix 18 can advantageously contain vitamins.

Preferably, this lipid matrix 18 comprises a high content of omega 6 and omega 3, in particular of DHA and EPA types. The lipid matrix 18 advantageously comprises at least 1% by weight of omega 3 of DHA and EPA types relative to the weight of the lipid matrix 18. It also preferably comprises less than 30% by weight of omega 3 of DHA and EPA types and very preferably less than 10% by weight relative to the weight of the lipid matrix 18. According to an advantageous embodiment, the lipid phase 18 comprises a mineral filler, advantageously an exfoliated mineral filler.

Advantageously, the exfoliated mineral filler has a specific surface area greater than 100 m ² / g, advantageously between 100 m ² / g and 800 m ² / g, more advantageously between 200 and 500 m ² / g. The mineral filler is advantageously chosen from the group of phyllosilicates, such as clays, talcs and micas.

Preferably, the phyllosilicate is a smectite. The smectites have the advantage, by their lamellar structure with a spacing between the lamellae greater than the other phyllosilicates, of being able to be swollen by small molecules with hydrophobic properties which will improve the exfoliation of clay platelets and thus facilitate their dispersion in lipid matrix 18. Micas and talcs can also be exfoliated in this way, but the energy that would be required to disperse the lamellar leaflets in lipid matrix 18 would be much higher. According to an advantageous embodiment, the content of the mineral filler in the lipid matrix 18 is between 0.5 and 35% by weight and preferably less than 15% by weight, that is to say included between 0.5% and 15% by weight, relative to the weight of the lipid matrix.

The presence of this mineral filler in the lipid matrix 18 has several important advantages. First, the load helps control the buoyancy of the products when used in aquaculture. It also strengthens the resistance of products to the action of oxygen by greatly reducing its diffusion kinetics in the nucleus 12 of the products and acts as a barrier to limit the leakage of small molecules of nutrients and active substances. Finally, the very high developed surface of the smectite sheets makes it possible to microstructure the lipid matrix 18 at the nanometric scale, which makes it possible to compartmentalize and play on the digestibility kinetics of the lipid matrix 18.

The third element or object of this first product 10 is a gelled protein phase 11 surrounding the lipid matrix 18, and thus surrounding the core 12. This protein phase 11 comprises proteins. This phase 11 is advantageously prepared from proteins dissolved in a gelled aqueous phase A2.

By "protide" is meant amino acids and all their oligomers and polymers, in particular oligopeptides, polypeptides and proteins.

The presence of this protein phase has the advantage of providing the target animal, in addition to the active substances, with the amino acids necessary for its growth, and of promoting the baitiness of the food 10.

The protein level of this protein phase 11 is between 6 and 95% by weight relative to the weight of a dry extract of the protein phase 11. Preferably, this level is between 45 and 80% by weight per relative to the weight of a dry extract of the protein phase 11.

Beyond 95% protein level, the gelation of the protein phase 11 becomes difficult, because the proteins block the reactive sites of the polysaccharides which may also be present in the protein phase 11, as described below. Below 6%, the nutritional intake becomes insufficient for food supplements. The protein phase 11 as shown in Figure 1 surrounds a single core 12 with a substantially spherical geometry. However, depending on the method used to disperse the nuclei 12 in the protein phase 11, the same product 10 may comprise several nuclei 12 dispersed in the protein phase 11. Consequently, the external geometry of the products 10 and of this protein phase 11 is very variable (see figure 11).

Preferably, the protein phase 11 comprises negatively charged and gelable polysaccharides, such as alginates, pectin, xanthan, gellan gum ... These polysaccharides are advantageously present in the aqueous phase A2 and will allow its gelation by reaction in particular of the polysaccharide and of the gelling agent. The gelling agent also advantageously allows crosslinking of the polysaccharides between them.

[0054] The negatively charged polysaccharides can be functionalized with a carboxylic, sulfonate, alcoholate or phosphate function, alone or in combination with positive charges (such as hyaluronic acid). The carboxylic function is preferred. The physicochemical conditions will be adjusted so as to have an excess of negative charges favoring the gelation conditions.

Advantageously, the gelled protein phase 11 is crosslinked by the action of a gelling agent released with a delay time which can be a metal capable of complexing with the functions, for example carboxylic polysaccharides or an inorganic or organic oligomer of load opposite to the charge of the target polysaccharide, i.e. the polysaccharide present in the protein phase 11.

Modulating the crosslinking delay time between 15 minutes and several hours makes it possible to promote mass mixing of the ingredients without caking of the gel, and thus to shape the food or food supplement 10.

The gelling agent can comprise cations of calcium, zinc, magnesium or transition metals and a source of acidic protons (such as pyrophosphate or deltagluconolactone) hydrolyzable in water, allowing the release of the ionic form .

Preferably, the gelled protein phase 11 may comprise a content of gelling polysaccharides of between 0.5 and 4.5% by weight and preferably less. at 2% by weight relative to the weight of the protein phase 11 gelled during the preparation of this protein phase 11, that is to say before the final drying phase of the product 10.

Preferably, the gelled protein phase 11 comprises a content of gelling polysaccharides of between 2 and 20% by weight and preferably between 2 and 10% by weight relative to the weight of a dry extract of the gelled protein phase 11. .

At less than 2% alginate in the protein phase 11, it is found that the gelation is insufficient for the stability of the product. Above 25% by weight, relative to the weight of a dry extract of protein phase 11, polysaccharides such as alginates play a laxative role by trapping more water and associated nutrients.

Advantageously, the proteins of the protein phase 11 comprise proteins of size less than 30 kDa. The digestion of these proteins can thus be done more quickly, because there are fewer bonds to cut to bring the peptide fragments to a size that can be assimilated by the digestive tract. According to an advantageous embodiment, the protein phase additionally comprises a dispersed mineral filler, such as silica, phyllosilicates, metal oxides, etc. The mineral filler is advantageously dispersed in the gelled aqueous phase A2.

This mineral filler, for example clay, has the advantage of making it possible to modulate the buoyancy of the products 10. It also constitutes a barrier which opposes the diffusion into the products 10 of oxygen. Indeed, the very high developed surface of the smectite sheets makes it possible to microstructure the protein matrix 11 at the nanometric scale which makes it possible to compartmentalize and to play on the digestibility kinetics of the protein matrix 11. Microstructure obtained by the interactions between the proteins. positively charged leaflets on the sides of the leaflet and negatively charged over the larger area of the leaflet with the polysaccharide, such as alginate, or proteins of the protein phase 11.

Advantageously, the mineral filler is a phyllosilicate and very advantageously a smectite.

Advantageously, the protein phase 11 comprises an osmotic agent. This osmotic agent can be chosen from the group of sugars, salts, water-soluble polymers, preferably with a molecular mass of less than 150 kg / mole, and their combinations.

A preferred choice may be sorbitol with a content of less than 5% by weight relative to the weight of the aqueous solution, that is to say the gelled aqueous phase A2 (in its complete formulation), so as not to make the final product indigestible 10. A content between 0.8 and 1.5% by weight is optimal. Guérande salt can also be used advantageously, which also makes it possible to provide useful mineral salts.

[0068] According to another advantageous characteristic, the whole of the protein phase 11 and of the core 12 is of any shape with a greater dimension of between 500 mhi and 5 mm.

The size of the products according to the invention can easily be adapted to the intended target, to be compatible with the supply capacities of the latter.

A subject of the invention is also a food with a total protein content which may be between 20 and 70% by weight relative to the weight of the whole of the finished product 10. This content is obtained after the last step optional product drying. The proteins are essentially supplied by the protein phase 11. In particular, from 80% to 100% by weight, advantageously from 90% to 100% by weight, of the proteins in the food are supplied by the protein phase. A subject of the invention is also a food with a total protein content advantageously between 40 and 80% by weight relative to the weight of a dry extract of the whole of the finished product. The proteins are essentially supplied by the protein phase 11. In particular, from 80% to 100% by weight, advantageously from 90% to 100% by weight, of the proteins in the food are supplied by the protein phase. Another object of the invention is also a food supplement with a total protein content which may be between 10 and 20% by weight relative to the weight of the whole of the finished product. This content is obtained after the last optional step of drying the product. Proteins are mainly provided by the protein phase. In particular, from 80% to 100% by weight, advantageously from 90% to 100% by weight, of the proteins of the food supplement are provided by the protein phase. Another object of the invention is also a food supplement with a total protein content advantageously between 3 and 40% by weight relative to the weight of a dry extract of the whole of the finished product 10. The proteins are essentially provided by the protein phase IL In particular, from 80% to 100% by weight, advantageously from 90% to 100% by weight, of the proteins of the food supplement are provided by the protein phase 11.

The proteins of the protein phase 11 are predigested, at least in part, in the stomach of the animal, but the gelation of this protein phase 11 coupled with the coating 14 constitutes a physical barrier to the release of these proteins. predigested in the stomach. It is interesting to limit such release of predigested proteins in the stomach because their metabolization in the stomach would be used to create digestion and motor energy by causing in aquaculture species releases of ammonia type resulting from this catabolization, at the same time. instead of being metabolized in the intestines of animals, where their absorption is most efficient for the growth of these animals.

The fourth element or object of this first product 10 is to include a coating 14 around the core 12 and the protein phase 11.

This coating 14 may comprise n layers C of biocompatible materials M + and M-, in particular of biopolymers, with an alternating stack of positive and negative electrostatic charges which form coacervates structured in a stack of layers, and n is at least equal to 1.

This coating 14 may comprise n layers C of biocompatible materials M + and M-, in particular of biopolymers, with an alternating stack of positive and negative electrostatic charges which form crosslinked and structured coacervates in a stack of layers, n being at least equal to 2.

The C + layer (s) comprising the biocompatible material with positive electrostatic charges M + comprise a crosslinking agent R- chosen from multicharged anions.

The layer (s) C- comprising the biocompatible material of negative electrostatic charges M- comprise a crosslinking agent R + chosen from multivalent cations. Thus, each layer C comprises a biocompatible material M with electrostatic charges, that is to say a biocompatible material bearing functional groups that can be ionized and ionized under the appropriate physicochemical conditions. These charges can be positive electrostatic charges and then the biocompatible material, denoted M +, comprises cationic functional groups, such as, for example, amine functions. These charges can be negative electrostatic charges and then the biocompatible material, denoted M-, comprises anionic functional groups, such as, for example, carboxylic acid, sulphonate, alcoholate or phosphate functions. Each layer C comprises, in addition to the biocompatible material M, a crosslinking agent R. This crosslinking agent also comprises electrostatic charges, of charges opposite to that of the material M. However, the total electrostatic charge of the layer C corresponds to that of material M. In fact, in layer C, the ratio (number of electrostatic charges of the biocompatible material, denoted nM / number of electrostatic charges of the crosslinking agent, denoted nR) (i.e. nM / nR) is strictly greater to 1, advantageously greater than 2, more advantageously greater than or equal to 5.

Thus, the layer comprising the material M +, denoted C + layer, also comprises a crosslinking agent comprising negative charges, denoted R-. The C + layer is globally positively charged. In fact, in the C + layer, the ratio (number of positive electrostatic charges of the biocompatible material, denoted nM + / number of negative electrostatic charges of the crosslinking agent nR-) (i.e. nM + / nR-) is strictly greater than 1, advantageously greater than 2, more advantageously greater than or equal to 5.

Thus, the layer comprising the material M-, denoted layer C- also comprises a crosslinking agent comprising positive charges, denoted R +. The C- layer is globally negatively charged. In fact, in the C- layer, the ratio (number of negative electrostatic charges of the biocompatible material, denoted nM- / number of positive electrostatic charges of the crosslinking agent nR +) (i.e. nM- / nR +) is strictly greater than 1 , advantageously greater than 2, more advantageously greater than or equal to 5. In each type of layer C, the modulation of the ratio nM / nR, or nM + / nR- or nM- / nR +, makes it possible to modulate the rigidity of the coating 14. By way of example, when the agent of crosslinking is added in a content making it possible to have an nM / nR ratio of 5/1 a very rigid coating is obtained and when the crosslinking agent is added in a content making it possible to have an nM / nR ratio of 100 / 1, a much more flexible mesh is obtained.

The ratio nM / nR advantageously varies from 2/1 to 300/1, more advantageously from 5/1 to 150/1.

This coating system 14 has the advantage of facilitating the modulation of the thickness of the coating layer 14 and the wide choice of biocompatible materials, in particular biopolymers, M + and M-, makes it possible to modulate the mesh of biocompatible materials, in particular biopolymers, on the surface, which is also stiffened by more or less strong crosslinks of this mesh. Modulating the rigidity of the coating 14 makes it possible to modulate the release of nutrient and / or physiologically active substances: the more the rigidification is dense, the more the biopolymer mesh is reduced and the release is slowed down. This type of crosslinked coating 14 and structured in multilayers C also makes it possible to obtain a structural stability necessary for the preservation of the food 10 until its consumption and the release of nutritive and / or physiologically active substances, and in particular necessary for its handling.

The R + crosslinking agent is chosen from multivalent cations. Advantageously, the multivalent cations are chosen from the group of alkaline earths, transition metals and poor metals.

Very advantageously, the multivalent cations are chosen from the group of cations of calcium, magnesium, manganese, iron, copper, zinc, aluminum and their combinations. It should be noted that the multivalent cations can be provided by salts then also comprising an anion. What is important is that the compound used allows the release of a cation which will be able to react with the negative charges of the biocompatible material M- and thus contribute to the crosslinking of the C- layer.

The R- crosslinking agent is chosen from multicharged anions. The term “multicharged anion” is understood to mean a chemical compound comprising several groups. functionally charged negatively. The functional group can be monovalent or multivalent. According to a preferred embodiment, the multicharged anions are polyphosphates. Preferably, the R- crosslinking agent is chosen from sodium trimetaphosphate (STMP), sodium hexametaphosphate and their mixture, preferably sodium trimetaphosphate (STMP).

Advantageously, in each C + layer, the biocompatible material M + is a biopolymer, in particular chosen from positively charged polysaccharides, advantageously chosen from polypeptides, chitosan, chitin derivatives, gums used as amine functionalized texturing agent such as as functionalized guar gum, and mixtures thereof. More advantageously, the biocompatible material M + is chosen from chitosan.

Advantageously, in each C + layer, the M + biopolymer is chitosan and the R- crosslinking agent is advantageously sodium trimetaphosphate (SMTP).

Advantageously, in each layer C-, the biocompatible material M- is a biopolymer, in particular chosen from negatively charged polysaccharides, advantageously chosen from polypeptides, pectin, acacia, xanthan, alginates, carrageenans , cellulose derivatives, and mixtures thereof. More advantageously, the biocompatible material M- is chosen from alginates, pectin and their mixtures.

Advantageously, in each layer C-, the biopolymer M- is chosen from alginates or pectin, and the crosslinking agent R + is advantageously chosen from calcium cations.

Advantageously, in each C + layer, the crosslinking agent R- is introduced at a specific content making it possible to obtain an nM + / nR- ratio of between 5/1 and 150/1. In particular, in each C + layer, the crosslinking agent R- is introduced at a content of between 0.5 g and 2 g per 1 g of M + for the high levels of crosslinking, and between 15 and 70 mg per 1 g of M + for low levels of crosslinking +.

Advantageously, in each layer C-, the crosslinking agent R + is introduced at a specific content making it possible to obtain an nM- / nR + ratio of between 5/1 and 150/1. In particular, in each C- layer, the crosslinking agent R + is introduced at a content between 0.5 g and 2 g per 1 g of M- for high levels of crosslinking and between 15 and 70 mg per 1 g of M-.

Advantageously, the layers C thus comprise bonds between the material M and the crosslinking agent R by metal complexation for the C- layer or chemical bridging for the C + layer.

N is an integer n is advantageously less than or equal to 15, more advantageously between 2 and 15, and preferably between 2 and 10.

This variable number of C layers is suitable for obtaining a good compromise between the quality of the encapsulation and the controlled release into the digestive tract while allowing easy implementation.

The outer layer of this coating 14 is preferably made of a positively charged polymer, that is to say a C + layer, because this has antibacterial properties and thus improves the preservation of the food or the dietary supplement.

[00101] The implementation of two crosslinking chemistries, metal complexation and chemical bridging, for coating 14 allows for a release trigger of nutrients depending on the progress in the digestion cycle. Thus, the digestion of proteins is promoted thanks to the release in an acidic medium of multivalent metal ions (which are complexed with the electron donors) which increases the permeability of the coating 14 to the acid present in the stomach, while delaying the release of the digesta, because the polycation layer remains crosslinked by the phosphoramide bridges obtained by the action of sodium trimetaphosphate (STMP). These latter crosslinking points are then released by the action of alkaline phosphatase enzymes usually secreted by the liver and released into the digestive tract via the bile. The food or food supplement thus releases its pre-digested nutrients into the digestive tract with slower kinetics, promoting the efficiency of absorption and the metabolic pathways most favorable to the zootechnical performance of the target animals.

Advantageously, the core 12 and / or the protein phase 11 also comprise) a charged polymer, or proteins with surface charges or cationic, anionic or zwitterionic surfactants. One can also specifically add biopolymers charged to the core 12 and / or the protein phase 11 to generate these charges. They will be chosen from anionic or cationic biopolymers mentioned above, but can also combine the charges as in hyaluronic acid. This makes it possible to modulate the residual or free charges by adjusting the pH conditions of the medium or by adjusting the stoichiometric balance of the complexation systems in the protein phase 11.

The physico-chemical system is thus adjusted so as to obtain an excess of free amines obtained from proteins of the protein phase 11 which will be positively charged under pH conditions below 9. This excess of positive charges is the condition necessary to deposit the first layer of anionic biopolymer C- of the coating 14.

If necessary, if the physicochemical system of the protein layer 11 rather exhibits an excess of negative charges, linked to the balance of the ingredients which constitute it, the coating 14 will begin with a first layer of cationic biopolymers C + .

The coating 14 of the protein phase 11 and / or of the core 12 may also include a layer of MR reinforcing materials.

These MR reinforcing materials can be chosen from the group of clays, silicas and filled fibers, and their combinations.

[00109] These MR reinforcing materials have a predominance of negative electrostatic charges on their surfaces and are thus attracted by the positive surface charges of the coating. It is thus possible to place a reinforcing layer MR between two layers of cationic C + biopolymers. Preferably, the MR reinforcing materials are a phyllosilicate and very preferably a smectite.

The use of MR reinforcing materials of high specific surface, that is to say a specific surface greater than 100 m ² / g, makes it possible to promote the interaction with the macromolecules of the coacervate, which reinforces their intercalation. in the coating 14, while developing a large surface of interaction with the incoming molecules (oxygen, oxidizing molecules) or outgoing (nutrients) while increasing the mean free path which results in a slowing down of the oxidation kinetics of nutrients and better encapsulations of small molecules.

This coating 14 therefore consists of layers of C + and C- biopolymers, advantageously of polysaccharides, charged alternately positively or negatively. In the animal's stomach, the pH is acidic and it is the mesh of positively charged biopolymers, layer C +, which is most resistant to this acidic pH and which ensures the integrity of the coating.

[00113] The C- layers of the coating 14 are advantageously bridged by cations such as Ca ++. These bridges are dissolved in an acidic medium, so when we arrive in a neutral to basic medium (the intestines) we have a real liberation of all the layers of the coating 14. As soon as there is a breach in the 'coating 14 the enzymes of the bile will be able to penetrate to the nucleus 12 and cause the release of lipids as well as their nutrients and active substances, leading very quickly also to the release of the particles 16 from the aqueous phase as well as their nutrients and active substances. This coating 14 therefore ensures the rapid release of all the nutrients and active substances in the area of the intestines of monogastric animals, where their absorption during their journey is the most efficient possible.

[00114] This product 10 is designed to provide nutritional balance in growing animals, which have to cope with pathogens and the stress of the breeding environment. Thus, this product 10 is recommended in the form of food or food supplement in the juvenile stage of monogastric species exhibiting significant mortality: such as in avian breeding, for example for chicks, or in aquaculture for fry. The flexibility of formulation and modulation of the properties, also makes it an interesting product to accompany the finishing of pre-commercial animals.

FIG. 2 shows a second product 20 comprising a protein phase 11 according to one of the objects of the invention. This second product 20 is similar to the first product 10. It comprises, like product 10, a core 22 comprising an aqueous phase composed of aqueous particles 16 dispersed in a lipid matrix 18, a protein phase 11 surrounding the lipid matrix 18 and the all surrounded by a coating 14. [00117] This second product 20 also comprises a coating or coating 24 of the lipid matrix 18 placed between this lipid matrix 18 and the protein phase 11.

Like the coating 14 of the product 20, this coating 24 comprises n layers C 'of biocompatible materials M, formed by an alternating stack of positive and negative electrostatic charges forming coacervates structured layer by layer, n being at least equal to 1. Preferably, the number of layers n is between 2 and 10. n is an integer. The C ’layers meet the same definitions as the C layers described above. The biocompatible materials M are as described above for coating 14.

More particularly, this coating 24 comprises n layers C 'of biocompatible materials with an alternating stack of positive and negative electrostatic charges which form crosslinked and structured coacervates in a stack of layers, n being at least equal to 2. This coating 24 thus comprises at least one C ′ + layer corresponding to the same definition as the C + layer described above for the coating 14 and at least one C′- layer corresponding to the same definition as the C- layer described above for the coating 14. De preferably, the number of layers n is between 2 and 10. n is an integer. The biocompatible materials M are as described above for coating 14, ie as described for M + and M-.

This addition of the coating 24 allows if necessary to delay the release of the active components of the internal phase of the core 12. The outer layer of this coating 24 is preferably made of a positively charged polymer, C + layer, because this has bactericidal properties and thus the preservation of the food or of the food supplement is improved.

This second architecture makes it possible to meet the requirements of even later release in the digestive tract of the internal phase of the nucleus 12, such as the release prebiotics or probiotics which must remain intact until the terminal phase of the digestive tract.

[00122] FIG. 4 shows the different steps of a process for manufacturing the first product 10. [00122] The core or cores 12 of the first product 10 are prepared from a double water-in-oil-in-water emulsion followed by filtration or decantation. Then this core 12 is completed by a protein phase 11 which will be shaped to the size and the target geometry. A coating 14 is then carried out. The last optional step of preparing the products is drying to bring the moisture content of the products 10 to a value less than 10% by weight, relative to the total weight of the product 10. This drying is carried out at low temperature, preferably below 50 ° C, for example between 18 ° C and 50 ° C.

[00124] Step (a) consists in preparing an aqueous phase by dispersing the necessary water-soluble active substances in water and adding the gelling reagents. These reagents are as described above for the gelled aqueous phase A, and can be a polysaccharide, a calcium salt, in particular calcium sulfate or calcium carbonate, in the presence of pyrophosphate or deltagluconolactone.

[00125] Step (a ’) consists in preparing a gelled protein phase by dispersing proteins in water with the gelling reagents described above, optionally an osmotic agent and optionally inorganic fillers such as phyllosilicates.

In step (b), the aqueous phase from step (a) is injected into a vegetable or animal oil to obtain a first emulsion of aqueous particles in the oil. Then, left to stand or moderately heated, to less than 100 ° C and ideally to less than 60 ° C, for example from 40 ° C to 60 ° C, this first emulsion to complete the gelation reactions of the particles and obtain robust gelled aqueous particles dispersed in the oil (step (c)).

The first emulsion from step (c) is then added to a mixture of animal or vegetable oil and liquid wax prepared beforehand. The oil + wax mixture advantageously comprises from 1 to 50% by weight of wax relative to the total weight of the mixture, more advantageously from 5 to 15% by weight of wax. For the crystallizable wax (s) used to be liquid, the temperature of the mixture is higher than the melting point of the waxes (step (d)). In step (e), the whole of the first emulsion and the mixture of oil and liquid wax, resulting from step (d), are introduced into an aqueous solution with stirring to obtain a second emulsion; this second emulsion comprises the gelled aqueous particles of the first emulsion dispersed in a lipid matrix which is itself in the form of particles dispersed in the aqueous solution. This second emulsion from step (e) is cooled in step (f) to a temperature below the solidification temperature of the crystallizable waxes present in order to stabilize the lipid particles.

It remains in step (g) to isolate the nuclei or lipid particles of the products by filtration or decantation by removing the aqueous phase. After step (g), the lipid particles from step (g) are dispersed in the protein phase 11 during gelation prepared in step (a ’). Homogenization is done with minimum shear. The dispersion is then, for example, introduced into a cold extruder to shape the product through a die. On leaving the die, the extrudate is continuously cut with a rotary blade to the target size and sets are obtained consisting of cores 12 coated with a protein phase 11 ready to be coated.

This addition of the protein phase 11 can also be carried out in a fluidized bed or in spheronization.

The chosen processes, extrusion, fluidized bed, spheronization, are implemented at low temperature, below 50 ° C (step (h)), for example ranging from 18 ° C to 50 ° C.

Note: the gelation kinetics of the protein phase 11 is adjusted to allow all the operations of step (h) to be carried out. The gelation is not completed at the end of step (h) until after a standing time allowing the solidification of the layer. It should be noted that due to their method of manufacture by preparing emulsions, the aqueous phases 16 and the lipid particles 18 have a relatively spherical geometry. On the other hand, the assemblies made up of the protein phase 11 surrounding the lipid phase 18 of the products 20 which are obtained by cutting an extrudate from a die can take any shape.

Finally, in step (i) the coating 14 is formed of the assemblies consisting of the protein phase 11 surrounding the lipid phase 18 obtained from step (h) by immersions in an aqueous bath in which one will alternately add solutions of cationic M + and anionic M- biocompatible materials. After the coating of step (i), the products are advantageously dried by air flow at low temperature to bring the humidity level to a value less than 10% by weight, relative to the total weight of the product. This increases the shelf life of the products. This last step is optional.

Figure 3 illustrates this formation of the coating 14 of the assemblies consisting of the protein phase 11 surrounding the lipid phase 18 from step (h) by successive additions of biopolymers, preferably polysaccharides, positively M + and negatively charged M-.

Note: the representation of the protein phase of Figure 3 has been modified from that of the other figures for clarity. Note: the whole is shown schematically in the form of a particle but it can have any shape

To the left of Figure 3, we see the assembly consisting of a core 12 of the first product 10 surrounded by a protein phase 11. This protein layer 11 comprises free surface charges, positive or negative. This assembly is coated by the addition of an aqueous solution of 52 M- negatively charged biopolymers, for example polysaccharides.

By electrostatic interactions, the negatively charged biopolymer M- will cover the surface of the assembly to form a negative layer C- of coacervate. Then added to the dispersion with the particles now negatively charged at the surface, an aqueous solution of positively charged biopolymer 54 M +. This will then spontaneously cover the layer C- previously placed.

The operation is repeated by alternating the aqueous solutions of positively M + and negatively M- charged biopolymers until a coating 14 is obtained comprising the desired number n of layers. Usually n is between 2 and 10.

Advantageously, in step (e), the continuous aqueous solution in which the second emulsion is produced (emulsion of lipids with wax) comprises at least one osmotic agent and at least one surfactant. The osmotic agent can be chosen from the group of sugars, salts, water-soluble polymers with a molecular mass of less than 150 kg / mole, and combinations thereof.

A preferred choice may be sorbitol with a content of less than 5% by weight relative to the weight of the continuous aqueous solution so as not to make the final product indigestible. A content between 0.8 and 1.5% by weight is optimal. Guérande salt can also be used advantageously, which also makes it possible to provide useful mineral salts.

The presence of an osmotic agent has the advantage of setting up an osmotic barrier which prevents the passage of the active substances present in the aqueous phase of the first emulsion which also contains an osmotic agent, of the same nature or different from that of the external continuous phase, advantageously from those described above; this internal aqueous phase being itself dispersed in the lipid phase. The osmotic agent helps to ensure a balance of osmotic pressures. This avoids a pumping effect of nutrients through the lipid wall.

Very advantageously, the surfactant is chosen from the group of phospholipids, polymers such as carboxymethylcellulose (CMC), hyaluronic acid, polylysines, proteins such as casein or hydrolysates of plant or animal proteins, surfactants, and combinations thereof.

FIG. 4 also shows an additional and optional step (a ”) in which a dispersion of a mineral phase such as clays is carried out in at least part of the mixture of animal or vegetable oils and of liquid waxes used in step (d). As previously indicated, these clays are preferably phyllosilicates and very preferably smectites.

To facilitate the exfoliation of the clay layers, the dispersion is carried out in the presence of a surfactant, which preferably has a cationic polar head.

One can advantageously use lecithin, betaine, polylisin, as well as their combinations.

FIG. 4 also shows another additional and optional step (c ') in which, before heating the first emulsion of aqueous particles in oil (step (c)), it is subjected to high shear such that rotor / stator to homogenize and reduce the size of these aqueous particles.

Figure 5 shows the additional steps for the preparation of the second product 20.

After step (g) which makes it possible to obtain the lipid particles 18 by filtration or decantation, a coating 24 of these lipid particles 18 is formed by successive injections of solutions of biopolymers, advantageously of polysaccharides, positively charged M + and negatively M- (step (g ')). The last addition is preferably that of a positively charged M + biopolymer. The steps for forming this coating 24 are as described above for step (i).

Then, the coated lipid particles 18 thus obtained following step (g ’) are dispersed in a protein phase 11, and the whole will be shaped by cold extrusion. The addition of the particles in the protein phase 11 can also be done by deposition in a fluidized bed or by spheronization. We obtain cylinders or geometries (depending on the die used) of the protein phase 11 in which the cores 22 of the second products are dispersed 20. These extrudas must then be cut, for example with a rotary blade, to obtain the sets of the cores 22. coated with coatings 24 dispersed in a protein phase 11 of the third products (step (h)).

It remains to carry out the coating 14 to obtain these second products 20 (step (i)). This coating 14 is carried out as previously described. The second products 20 can also be dried under a flow of air at low temperature, preferably lower. at 50 ° C, until the humidity level is less than 10% by weight, relative to the total weight of the product 20.

Preparation of a food supplement

[00160] An example of the preparation of a food supplement of the first product is now described.

Preparation of the Gelled Internal Aqueous Phase This preparation comprises the following steps:

[00162] A beaker is filled with water. Then the hydrophilic nutrients to be encapsulated are added. These nutrient intakes represent around 30% by weight based on the weight of the water in the beaker. The solution is then mixed in a high shear rotor-stator mixer of the Silverson Mixer type, L5M-A for 1 min at 1000 rpm (revolutions per minute). Then, 3.5% by weight of sodium alginate is added to the previous solution. Mix with the high shear mixer for 5 min at 2000 rpm. After complete dispersion of the above alginate, 0.5% by weight of pyrophosphate and 1.75% by weight of calcium sulfate are added simultaneously. The mixture is rapidly homogenized in a rotor-stator mixer at 2000 rpm, then all of this aqueous phase is poured into a volume of cod liver oil serving as a dispersion medium. The ratio of the volume of oil to the volume of the aqueous phase is less than 3.4. The whole is mixed thoroughly with the high shear mixer at 2000 rpm to reduce the size of the water droplets in the oil before the aqueous phase gels. Allowed to stand for 15 min for the aqueous phase particles to solidify.

FIG. 5 shows the size distribution of the gelled aqueous particles obtained. The average size of the aqueous phase particles obtained with the shear rate at 2000 rpm is 161 µm. The average size can be reduced by increasing the shear rate of the solution, or by changing the viscosity of the alginate solution. By reducing the concentration of alginate in the solution from 3.5% by weight to 2% by weight, a decrease in viscosity of more than a factor of 10 was obtained. The shearing is then more efficient and the average size of the particles. decreases. Preparation of the crystallizable lipid phase

Preparation of a first beaker of melted wax

In a first beaker is added a given mass of beeswax or sodium stearate, and a mass of sunflower oil 15% greater than the mass of beeswax or sodium stearate. The sum of the two ingredients represents 25.5% by weight of the total mass of the lipid phase prepared. Then the first beaker is placed in a water bath preheated to 75 ° C until the wax has completely melted (wax melting temperature 60 to 63 ° C).

Preparation of a second beaker of clay exfoliated in oil [00165] In a second beaker, 100 units of weight of rapeseed oil, 30 units of weight of linseed oil, 1.24 units of weight are added. of betaine citrate, 1.24 weight units of soya lecithin, 50 weight units of montmorillonite pre-impregnated with 10% by weight of water relative to the weight of montmorillonite. The whole is mixed with the high shear mixer for 30 min at 2000 rpm. The mixture is completed with specific contributions such as vitamins A, E, D, K etc ... for less than 0.2 units of weight. The exfoliated clay preparation represents about 30% by weight based on the total mass of the prepared lipid phase. The quality of the exfoliation of montmorillonite in oil can be assessed by light microscopy by observing the homogeneity of the dispersion, with the reduction of macroscopic aggregates of several hundred µm.

Combining the prepared lipid phases in a third beaker

In a third beaker, kept in a water bath at 70 ° C, the prepared oil phases are combined in the following proportions:

- 44% by weight of the dispersion of aqueous particles gelled in a lipid matrix of cod liver oil prepared above;

- 31% by weight of the mixture of the second beaker (rapeseed and linseed oils, exfoliated montmorillonite, etc.); and

- 25% by weight of the mixture of liquid waxes and sunflower oil prepared previously. Homogenized with a high shear mixer for 2 min at 1000 rpm. An oil phase is obtained which is ready to be dispersed to form the enriched lipid particles.

Preparation of the external aqueous phase [00168] In a jacketed reactor, equipped with a stirrer and temperature control, an aqueous solution is prepared according to the following composition:

- water for a volume equivalent to 2.5 times the volume of the lipid phase to be dispersed;

- 1% by weight relative to the mass of the aqueous solution of osmotic agent (sorbitol or sodium chloride); and

- 0.4% by weight relative to the mass of the aqueous solution of casein (surfactant, which can be substituted by animal or vegetable proteins).

Homogenize until the ingredients are completely dissolved, and the solution is brought to 65 ° C. Manufacture of lipid particles

With a stirrer capable of dispersing solids, the aqueous phase is stirred continuously at 450 rpm while maintaining the temperature at 65 ° C. Then, all of the lipid phase prepared above and maintained at 70 ° C. is quickly poured into the external aqueous phase. The dispersion is allowed to stabilize until it reaches about 62 ° C, the stirring is reduced to 400 rpm, the mixture is cooled with the jacket of the reactor to reach 60 ° C, the stirring is reduced to 350 rpm, the mixing is accelerated. cooling by adding ice-cold water to rapidly reach 45 ° C., the lipid particles are allowed to cool to room temperature via the jacket of the reactor while maintaining stirring at 150 rpm. When the dispersion is below 25 ° C, the solidified lipid particles are filtered through a sieve.

The lipid particles thus obtained are characterized in size using a Malvem Mastersizer 3000 particle size analyzer with a liquid dispersion by hydro EV, with the software of the size determination apparatus (Fraunhôfer's equation). The measurements were carried out on 3 manufacturing tests: the three tests give the same average size of the lipid particles of 330 μm (FIG. 7). FIG. 8 shows the change in the iodine number measured according to standard NF EN ISO 3961 (September 2013), during aging of the lipid particles in the open air. Line L1 gives the reference iodine number obtained from the formulation of the particles. Lines L2 and L3 give the upper and lower 95% confidence limits and line L4 the evolution of the measured iodine number of the lipid particles. This line L4 shows that all the measurements after the first are within the interval between the high and low confidence limits and this makes it possible to confirm the storage stability of the particles thanks in particular to the increase in the mean path of the particles. oxygen molecules imposed by the presence of clay. Thus during storage, no significant variation is observed in the number of unsaturations (double bonds resulting from omega 3-6 and 9) provided by the oils used for the formulation.

[00173] Figure 9 shows an image of a lipid particle obtained under a scanning electron microscope.

Outer protein layer - preparation of the protein layer covering the lipid particles

Preparation of the protein matrix containing the lipid particles:

In a planetary mixer type kneader, we introduce:

- 100 parts by weight of the protein formulation corresponding to the nutritional requirements of the target species;

- 33 parts by weight of sodium alginate;

- 8.3 parts by weight of pyrophosphate;

- 33 parts by weight of calcium sulphate;

- 1 part by weight of sorbitol (osmotic agent)

- nutritional additives according to the nutritional target (quantity less than 2 parts by weight).

After homogenization of the solids, a volume of water is added, the mass of which corresponds to 600 parts by weight, and the mixture is vigorously homogenized with the planetary kneader type mixer for 10 min.

A mass of lipid particles corresponding to 630 parts by weight is introduced. Note: the residual moisture of the lipid particles must be taken into account which can vary from 2 to 50% by weight. Then it is homogenized while limiting the shearing until a homogeneous paste is obtained. This dough is then introduced into a cold single-screw extruder to shape the dough through a die at the target diameter of the size of the food supplement. The extrudate is continuously cut by a rotating blade to the target size of the food supplement.

The protein particles are left to stand for two hours to obtain their solidification.

[00178] The solidification kinetics of the food were characterized using the ARES-G2 rheometer of T A-instrument, with the 40 mm ² cone / plane mobile. A 5 ° rotary shear was applied at a frequency of 1 Hz, and the change in force over time was measured.

FIG. 10 shows a curve for monitoring the rheological behavior of the protein layer in the case of a protein phase obtained with 2% by weight of alginate and 15% by weight of proteins relative to the total weight of the phase protein. This figure gives the evolution as a function of time of the measured modules G ’and G”.

[00180] A destructuring of the polyelectrolyte / protein gel is observed at short observation times, with a decrease in the shear force G ’, marking several levels. Then a resumption of force beyond 3800 seconds, reflecting the emergence of a percolating crosslinking domain between the two shear plates. This crosslinking seems to saturate at 8300 seconds, then there is a detachment probably related to the separation of the solidified sample from the wall of the cone / plane.

It is deduced from this that the mixture can be worked for approximately one hour without risking destroying the gelation mechanism, and with two consecutive hours of rest, the maximum level of rigidity of the food supplement is reached. The protein particles thus obtained can be stored in a cool place (4 ° C), or used for the coating step by depositing a layer of biopolymer layer-by-layer, in English "Layer by Layer".

FIG. 11 shows an example of protein particles obtained after gelation of a size of the order of a millimeter. Preparation of the release modulation coating by a biopolymer deposited layer by layer (in English "layer by layer")

Coating layer by layer

The procedure is described for 100 g of lipid particles dispersed in 300 g of water supplemented with 1% sorbitol.

[00184] A stirring mobile is used which promotes good homogenization, without inducing excessive shearing of the solution (double finned mobile).

We prepare:

- 2000 ml of a first aqueous solution of chitosan (M +) at 0.1% by weight relative to the weight of the aqueous solution (with 0.05% by weight of acetic acid);

- 2000 ml of a second aqueous solution of sodium alginate (M-) at 0.1% by weight;

- 200 ml of a third aqueous solution of calcium chloride (R +) at 2% by weight; and

- 200 ml of a fourth aqueous solution of SMTP (R-) at 0.5% by weight. Note: TSTP is obtained by chemical bridging of SMTP which is the reagent introduced.

[00186] The additions are started with the 0.1% by weight sodium alginate solution; stirred for 1 to 2 min between each addition. The chitosan solution is then added.

The procedure followed and the proportions of each addition are as follows (all the% are% by weight):

- + 20 ml of 0.1% sodium alginate solution;

- + 20 ml of 0.1% chitosan solution;

- + 60 ml of 0.1% sodium alginate solution;

- + 20 ml of 0.5% SMTP solution;

- +10 ml of 0.1% chitosan solution;

- + 100 ml of 2% calcium chloride solution;

- + 4.25 g of montmorillonite;

- + 10 ml of 0.1% chitosan solution;

- + 80 ml of 0.1% sodium alginate solution;

- + 20 ml of 0.1% chitosan solution; and - + 20 ml of 2% calcium chloride solution.

Stirred for 15 min at 370 rpm. This procedure results in a seven-layer coating, the first of which is anionic sodium alginate layer and the last is cationic chitosan. In the middle of the coating, there is a layer of smectite (montmorillonite) (MR) sheets. These operations could be repeated up to seven times in the laboratory.

Characterizations:

[00189] The lipid particles remain dispersed in solution, the non-flocculation is monitored with the naked eye over the course of the additions of charged biopolymers.

The conductimetric monitoring of the conductance of the solutions makes it possible to monitor the deposition of the charged biopolymers.

As a reference, the change in the conductivity of a pure water solution is measured, to which metered additions of 0.1% chitosan solution are made (curve Cl), then independently of the additions. dosed with 0.1% sodium alginate (curve C2), and finally the combination of the two (curve C3). Figure 12 shows the results obtained.

[00192] The increase in the conductivity of the solution is thus characterized during the additions of chitosan and sodium alginate, with a greater conductivity for the alginate. The combination of the two reagents results in a slower sawtooth increase in conductivity compared to that of anionic and cationic polymers alone, because the charges largely neutralize each other, and the radius of gyration of the coacervates becomes greater (conductivity apparent lower).

FIG. 13 shows the change in the conductivity of a solution of lipid particles during metered additions of loaded biopolymers. This figure shows that the addition of anionic and cationic biopolymers does not induce an increase in the conductivity of the solution, on the contrary, it decreases. It is the signature of the condensation of anionic (M-) and cationic (M +) biopolymers at the surface of the particles, leading to the decrease in the overall conductivity of the solution, because the large lipid particles contribute little to the conductivity, and the salts in solution (osmotic agent) are trapped in the interface during condensation, and no longer contribute to the conductivity of the solution. This last example concerned the coating of lipid particles, the procedure is similar when the lipid particles are dispersed in a protein phase to give protein particles.

[00195] The foods and food supplements which constitute some of the objects of the invention are therefore products with a modular architecture which make it possible to encapsulate various nutrients and active substances and to release them into the digestive system of the target animals.

[00196] The stabilization thanks to the materials of the coating allows it to resist the acidic environment of the stomach while allowing rapid disintegration in a subsequent basic medium which ensures a very rapid and effective re-release of all the nutrients and active substances where they are most effective.

The modular architecture of the core makes it possible to incorporate in the aqueous internal phase of the order of twenty different water-soluble active substances, in the first product, this incorporation takes place in particles of diameter of the order of 20 to 100 µm; in the internal lipid phase, it is also possible to incorporate around twenty different liposoluble active substances in a matrix with a diameter of around 400 µm or less.

[00198] The protein phase of the nucleus provides the target animal with the amino acids it needs and makes the product more baiting. The manufacturing process is also very respectful of these nutrients and active substances.

The products objects of the invention are thus with their modular architecture of very flexible use and by varying the manufacturing conditions, one can vary the respective dimensions of the particles and the cores as well as the nature and the quantity of the particles. active substances and nutrients to fine tune them to all target animals.

Claims

1. Food or food supplement allowing a controlled release of nutritive and / or physiologically active substances for monogastric animals, comprising a core 12 comprising an aqueous phase A containing water-soluble active substances dispersed in a lipid matrix 18 containing liposoluble active substances, and a coating 14 of the core 12, characterized in that said food or food supplement comprises a gelled protein phase 11 arranged between said lipid matrix 18 and said coating 14 and in that the level of proteins of said protein phase 11 is between 6 and 95% by weight relative to the weight of a dry extract of said protein phase 11.

2. Food or food supplement according to claim 1, wherein the protein level of said protein phase 11 is between 45 and 80% by weight, relative to the weight of a dry extract of the protein phase 11.

3. Food or food supplement according to any one of claims 1 and 2, wherein the total protein content of the food or food supplement is between 3 and 80% by weight, relative to the weight of a dry extract. of the food or food supplement.

4. Food or food supplement according to any one of claims 1 to 3, wherein said protein phase 11 comprises neutral or functionalised negatively charged polysaccharides, gellable and functionalized with a function chosen from the group of carboxylic, sulfonate, alcoholate or functions. phosphate, preferably carboxylic.

5. Food or food supplement according to claim 4, wherein the negatively charged polysaccharides are chosen from the group of alginate, pectin, xanthan, gellan gum and their combinations.

6. Food or food supplement according to any one of claims 4 and 5, wherein the gelled protein phase 11 is crosslinked by the action of a gelling agent released with a delay time which may be a metal capable of complexing with them. carboxylic functions of the polysaccharides or an inorganic or organic oligomer with a charge opposite to the charge of the target polysaccharide, and in which the gelling agent contains cations of calcium, zinc, magnesium, iron or transition metals and a source of acidic protons hydrolyzable in water, allowing the release of the ionic form under the action of the protons.

7. Food or food supplement according to any one of the preceding claims, in which the gelled protein phase 11 comprises a content of gellable polysaccharides of between 2 and 20% by weight and preferably between 2 and 10% by weight, relative to the weight of a dry extract of the protein phase 11.

8. Food or food supplement according to any one of the preceding claims, in which the proteins of said gelled protein phase 11 comprise proteins of size less than 30 kDa.

9. Food or food supplement according to any one of the preceding claims, in which the protein phase 11 comprises a mineral filler.

10. Food or food supplement according to any one of the preceding claims, in which the protein phase 11 comprises an osmotic agent.

11. Food or food supplement according to claim 10, wherein the osmotic agent is selected from the group of sugars, salts, water-soluble polymers preferably of molecular weight less than 150 kg / mole and combinations thereof.

12. Food or food supplement according to any one of the preceding claims, in which the protein phase 11 is of any shape with a greater dimension of between 500 μm and 5 mm.

13. Food supplement according to any one of the preceding claims, comprising a total protein content of between 3 and 40% by weight relative to the weight of a dry extract of the food supplement.

14. Food according to any one of claims 1 to 12, comprising a total protein content of between 40 and 80% by weight relative to the weight of a dry extract of the food